DE69626347D1 - Verfahren zur Passivierung eines photoreaktiven Mineralpigments durch Behandlung mittels eines kalten organischen Plasmas, und lichtechte, kosmetische oder pharmazeutische Zusammensetzung enthaltend mindenstens ein auf diese Weise passiviertes Pigment - Google Patents

Verfahren zur Passivierung eines photoreaktiven Mineralpigments durch Behandlung mittels eines kalten organischen Plasmas, und lichtechte, kosmetische oder pharmazeutische Zusammensetzung enthaltend mindenstens ein auf diese Weise passiviertes Pigment

Info

Publication number
DE69626347D1
DE69626347D1 DE69626347T DE69626347T DE69626347D1 DE 69626347 D1 DE69626347 D1 DE 69626347D1 DE 69626347 T DE69626347 T DE 69626347T DE 69626347 T DE69626347 T DE 69626347T DE 69626347 D1 DE69626347 D1 DE 69626347D1
Authority
DE
Germany
Prior art keywords
pigment
lightfast
photoreactive
passivation
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69626347T
Other languages
English (en)
Other versions
DE69626347T2 (de
Inventor
Jean-Luc Leveque
Frederic Leroy
Myriam Mellul
Yolanda Duvault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE69626347D1 publication Critical patent/DE69626347D1/de
Application granted granted Critical
Publication of DE69626347T2 publication Critical patent/DE69626347T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK  ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
    • C09C3/00—Treatment in general of inorganic materials, other than fibrous fillers, to enhance their pigmenting or filling properties
    • C09C3/04—Physical treatment, e.g. grinding, treatment with ultrasonic vibrations
    • C09C3/048—Treatment with a plasma
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK  ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
    • C09C3/00—Treatment in general of inorganic materials, other than fibrous fillers, to enhance their pigmenting or filling properties
    • C09C3/08—Treatment with low-molecular-weight non-polymer organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Plasma & Fusion (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Pigments, Carbon Blacks, Or Wood Stains (AREA)
DE1996626347 1995-08-09 1996-08-07 Verfahren zur Passivierung eines photoreaktiven Mineralpigments durch Behandlung mittels eines kalten organischen Plasmas, und lichtechte, kosmetische oder pharmazeutische Zusammensetzung enthaltend mindenstens ein auf diese Weise passiviertes Pigment Expired - Fee Related DE69626347T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509675 1995-08-09
FR9509675A FR2737728B1 (fr) 1995-08-09 1995-08-09 Procede de passivation d'un pigment mineral photoreactif par traitement par un plasma froid d'un gaz et composition cosmetique ou pharmaceutique, stable a la lumiere, contenant au moins un pigment ainsi passive

Publications (2)

Publication Number Publication Date
DE69626347D1 true DE69626347D1 (de) 2003-04-03
DE69626347T2 DE69626347T2 (de) 2004-04-29

Family

ID=9481829

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1996626347 Expired - Fee Related DE69626347T2 (de) 1995-08-09 1996-08-07 Verfahren zur Passivierung eines photoreaktiven Mineralpigments durch Behandlung mittels eines kalten organischen Plasmas, und lichtechte, kosmetische oder pharmazeutische Zusammensetzung enthaltend mindenstens ein auf diese Weise passiviertes Pigment

Country Status (5)

Country Link
EP (1) EP0758006B1 (de)
JP (1) JP3769328B2 (de)
DE (1) DE69626347T2 (de)
ES (1) ES2191081T3 (de)
FR (1) FR2737728B1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO688997A0 (en) * 1997-05-20 1997-06-12 Soltec Research Pty Ltd Sunscreen composition
JPH11124309A (ja) * 1997-10-22 1999-05-11 Kao Corp 化粧料
JP2004123633A (ja) * 2002-10-03 2004-04-22 Medorekkusu:Kk 外用製剤
JP4942513B2 (ja) * 2007-03-02 2012-05-30 株式会社Ａｄｅｋａ 塩化ビニル系樹脂組成物
DE102007022457A1 (de) * 2007-05-09 2008-11-13 Durtec Gmbh Plasmamodifizierte natürliche Minerale mit nanoskaligen Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung
CA2947531C (en) * 2014-05-14 2022-06-28 Amastan Technologies Llc Method for the densification and spheroidization of solid and solution precursor droplets of materials using plasma
JP6543753B2 (ja) * 2018-08-07 2019-07-10 アマスタン・テクノロジーズ・エル・エル・シー プラズマを使用して固体材料および材料の溶液前駆体液滴を高密度化および球状化する方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56134784A (en) * 1980-03-26 1981-10-21 Canon Inc Manufacture of photoconductive powder
JPS59175409A (ja) * 1983-03-23 1984-10-04 Shiseido Co Ltd 化粧料
JPS61190567A (ja) * 1985-02-19 1986-08-25 Shiseido Co Ltd 表面処理粉末
JPS63239102A (ja) * 1986-11-07 1988-10-05 Nippon Steel Corp 金属酸化物粉末の低温プラズマ処理方法
JP3297881B2 (ja) * 1992-10-27 2002-07-02 イーシー化学株式会社 超微粒子の表面処理方法

Also Published As

Publication number Publication date
EP0758006A1 (de) 1997-02-12
ES2191081T3 (es) 2003-09-01
EP0758006B1 (de) 2003-02-26
FR2737728A1 (fr) 1997-02-14
JPH09157542A (ja) 1997-06-17
DE69626347T2 (de) 2004-04-29
JP3769328B2 (ja) 2006-04-26
FR2737728B1 (fr) 1997-10-03

Similar Documents

Publication Publication Date Title
Shabani et al. Diosmin is neuroprotective in a rat model of scopolamine-induced cognitive impairment
ATE206305T1 (de) Verfahren zur behandlung von gemüts- oder geisteskrankheiten und von gemüts- oder geisteskrankheiten, die von anfällen begleitet sind
DE60015392D1 (de) Verwendung von annexin-modulatoren zur herstellung eines medikaments zur behandlung und/oder vorbeugung von arthritis und arthritischen erkrankungen
DE60039824D1 (de) Vorrichtung zur Behandlung von biologischen Geweben mittels Elektrizität oder Medikamenten
DE236684T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
ATE180408T1 (de) Herstellung eines arzneimittels zur behandlung von augenentzündung durch blockierung von zelladhäsionsmolekulen
DE69737510D1 (de) Verwendung eines unverkapselten anti-krebs-wirkstoffs zur herstellung einer zubereitung zur behandlung von neoplasmen durch inhalation
ATE202140T1 (de) Hemmung der neovaskulasierung durch vegf- spezifische oligonukleotide
BR0309167A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto, método para o tratamento de um sujeito afetado por uma condição patológica ou doença e produto de combinação
DE69435249D1 (de) Verwendung vom neurotoxischem Komponent von Botulinum toxin zur Behandlung von einem spastischem Muskel
BRPI0512220A (pt) método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
DE69618359D1 (de) Verfahren zur Oberflächenbehandlung eines Vorform, Verfahren zum Herstellen eines Vorform mittels genannter Oberflächenbehandlung und durch diese Verfahren hergestellter Vorform
BRPI0512213A (pt) método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
ATE275562T1 (de) Neue form vom irbesartan, verfahren um diese form zu erhalten und sie enthaltende pharmazeutische zusammensetzungen
DE10337184A1 (de) Substituierte 3-Pyrrolidin-Indol-Derivate
DE69325393D1 (de) Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen
DE69332402D1 (de) Verwendung eines behandlungsmittels für faserprodukte, verfahren zum behandeln von faserprodukten und die dadurch behandelten faserprodukte
DE69626347D1 (de) Verfahren zur Passivierung eines photoreaktiven Mineralpigments durch Behandlung mittels eines kalten organischen Plasmas, und lichtechte, kosmetische oder pharmazeutische Zusammensetzung enthaltend mindenstens ein auf diese Weise passiviertes Pigment
DE3751036D1 (de) Durch Carnitin dirigierte pharmazeutische Substanzen und ihre Verwendung zur Herstellung eines Arzneimittels zur Behandlung von Muskelerkrankungen.
BR0308957A (pt) Composto, composição farmacêutica, método para o tratamento de uma inflamação ou de uma desordem associada a uma inflamação em um paciente, uso dos compostos e processo para sua preparação
BR0309406A (pt) Composição farmacêutica, processo de preparação, kit e métodos para tratamento de obesidade, utilização de composição e inibidor de lìpases, inibidor de lìpáses e glucomanan ou konjac e utilização dos mesmos e método de tratamento
ATE173620T1 (de) Verwendung eines antagonisten von tnf-alpha zur behandlung von hautrötungen neurogenen ursprungs
TW200510437A (en) Phosphinane compound with immunomodulating activity
CA2342435A1 (en) A pharmaceutical composition for inhibiting non-intentional behavior and use of a running neuron inhibitory substance for producing the pharmaceutical composition
CA2319542A1 (en) The treatment of sexual dysfunction in certain patient groups

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: L'OREAL, PARIS, FR

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee